Comparison of whole genome amplification and nested-PCR methods for preimplantation genetic diagnosis for BRCA1 gene mutation on unfertilized oocytes–a pilot study
暂无分享,去创建一个
[1] Pgd,et al. Preimplantation genetic diagnosis. , 2019, Fertility and sterility.
[2] Danuta Januszkiewicz-Lewandowska,et al. Prevalence of the most frequent BRCA1 mutations in Polish population , 2011, Journal of Applied Genetics.
[3] Lindsey M. King,et al. Conflict between values and technology: perceptions of preimplantation genetic diagnosis among women at increased risk for hereditary breast and ovarian cancer , 2009, Familial Cancer.
[4] M. Werner,et al. Preimplantation genetic diagnosis for BRCA1/2—a novel clinical experience , 2009, Prenatal diagnosis.
[5] N. Muntjewerff,et al. ESHRE PGD Consortium data collection V: cycles from January to December 2002 with pregnancy follow-up to October 2003. , 2008, Human reproduction.
[6] I. Jacobs,et al. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. , 2007, Human reproduction.
[7] A. Nowicki,et al. [Self-examination influence on breast cancer detection. Research conducted in women after breast amputation]. , 2007, Ginekologia polska.
[8] S. Gayther,et al. Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention , 2006, Acta obstetricia et gynecologica Scandinavica.
[9] A. Jakubowska,et al. A high proportion of founder BRCA1 mutations in Polish breast cancer families , 2004, International journal of cancer.
[10] J. Hopper,et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.
[11] Å. Borg,et al. BRCA1 and BRCA2 mutation analysis in breast‐ovarian cancer families from northeastern Poland , 2003, Human mutation.
[12] B. Ponder,et al. The genetics of ovarian cancer. , 2002, Best practice & research. Clinical obstetrics & gynaecology.
[13] A. Jakubowska,et al. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. , 2000, American journal of human genetics.
[14] J. Ranstam,et al. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[16] B. Ponder,et al. Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. , 1997, American journal of human genetics.
[17] M. Morgan,et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. , 1996, The New England journal of medicine.
[18] A. H. Handyside,et al. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification , 1990, Nature.
[19] C. Moutou,et al. ESHRE PGD Consortium data collection IV: May-December 2001. , 2005, Human reproduction.
[20] T. Pieńkowski,et al. The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives. , 2004, European journal of gynaecological oncology.
[21] A. Jakubowska,et al. Molecular basis of inherited predispositions for tumors. , 2002, Acta biochimica Polonica.
[22] E. Grzybowska,et al. Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population. , 2002, Acta biochimica Polonica.